Fig. 2From: Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacyThe in vitro release profile of curcumin and paclitaxel from niosomal optimum formulaBack to article page